CD4+ memory stem cells are infected by HIV-1 in a manner regulated in part by SAMHD1 expression

Journal of Virology

Volumn 88, Issue 9, 2014, Pages 4976-4986

  Tabler, Caroline O ^a   Lucera, Mark B ^a   Haqqani, Aiman A ^a   McDonald, David J ^a   Migueles, Stephen A ^b   Connors, Mark ^b   Tilton, John C ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; PROTEIN SAMHD1; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; IN VIVO STUDY; INFECTION SENSITIVITY; LATENT VIRUS INFECTION; LYMPHOID PROGENITOR CELL; MEMORY T LYMPHOCYTE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE SUBPOPULATION; VIRUS LIKE AGENT; VIRUS STRAIN;

CD4-POSITIVE T-LYMPHOCYTES; GENE EXPRESSION; HEALTHY VOLUNTEERS; HIV-1; HUMANS; MONOMERIC GTP-BINDING PROTEINS; RECEPTORS, CCR5; RECEPTORS, CXCR4; RECEPTORS, HIV; STEM CELLS;

EID: 84897503749     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00324-14     Document Type: Article

References (48)

1. Hammarlund E, Lewis MW, Hansen SG, Strelow LI, Nelson JA, Sexton GJ, Hanifin JM, Slifka MK. 2003. Duration of antiviral immunity after smallpox vaccination. Nat. Med. 9:1131-1137. http://dx.doi.org/10.1038/nm917.
2. Perfetto SP, Chattopadhyay PK, Roederer M. 2004. Seventeen-colour flow cytometry: unravelling the immune system. Nat. Rev. Immunol. 4:648-655. http://dx.doi.org/10.1038/nri1416.
3. Gattinoni L, Klebanoff CA, Restifo NP. 2012. Paths to stemness: building the ultimate antitumour T cell. Nat. Rev. Cancer 12:671-684. http://dx.doi.org/10.1038/nrc3322.
4. Lugli E, Dominguez MH, Gattinoni L, Chattopadhyay PK, Bolton DL, Song K, Klatt NR, Brenchley JM, Vaccari M, Gostick E, Price DA, Waldmann TA, Restifo NP, Franchini G, Roederer M. 2013. Superior T memory stem cell persistence supports long-lived T cell memory. J. Clin. Invest. 123:594-599. http://dx.doi.org/10.1172/JCI66327.
5. Sallusto F, Lenig D, Förster R, Lipp M, Lanzavecchia A. 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401:708-712. http://dx.doi.org/10.1038/44385.
6. Sallusto F, Geginat J, Lanzavecchia A. 2004. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu. Rev. Immunol. 22:745-763. http://dx.doi.org/10.1146/annurev.immunol.22.012703.104702.
7. + memory T cells: functional modules for tailored immunity. Eur. J. Immunol. 39: 2076-2082. http://dx.doi.org/10.1002/eji.200939722.
8. Gattinoni L, Lugli E, Ji Y, Pos Z, Paulos CM, Quigley MF, Almeida JR, Gostick E, Yu Z, Carpenito C, Wang E, Douek DC, Price DA, June CH, Marincola FM, Roederer M, Restifo NP. 2011. A human memory T cell subset with stem cell-like properties. Nat. Med. 17:1290-1297. http://dx.doi.org/10.1038/nm.2446.
9. Gattinoni L, Zhong X-S, Palmer DC, Ji Y, Hinrichs CS, Yu Z, Wrzesinski C, Boni A, Cassard L, Garvin LM, Paulos CM, Muranski P, Restifo NP. 2009. Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells. Nat. Med. 15:808-813. http://dx.doi.org/10.1038/nm.1982.
10. Zhang Y, Joe G, Hexner E, Zhu J, Emerson SG. 2005. Host-reactive CD8+ memory stem cells in graft-versus-host disease. Nat. Med. 11:1299-1305. http://dx.doi.org/10.1038/nm1326.
11. Cieri N, Camisa B, Cocchiarella F, Forcato M, Oliveira G, Provasi E, Bondanza A, Bordignon C, Peccatori J, Ciceri F, Lupo-Stanghellini MT, Mavilio F, Mondino A, Bicciato S, Recchia A, Bonini C. 2013. IL-7 and IL-15 instruct the generation of human memory stem T cells from naive precursors. Blood 121:573-584. http://dx.doi.org/10.1182/blood-2012-05-431718.
12. + T cells. Nature 417:95-98. http://dx.doi.org/10.1038/417095a.
13. Demoustier A, Gubler B, Lambotte O, de Goër M-G, Wallon C, Goujard C, Delfraissy J-F, Taoufik Y. 2002. In patients on prolonged HAART, a significant pool of HIV infectedCD4T cells are HIV-specific. AIDS 16:1749-1754. http://dx.doi.org/10.1097/00002030-200209060-00006.
14. Harari A, Rizzardi GP, Ellefsen K, Ciuffreda D, Champagne P, Bart P-A, Kaufmann D, Telenti A, Sahli R, Tambussi G, Kaiser L, Lazzarin A, Perrin L, Pantaleo G. 2002. Analysis of HIV-1-and CMV-specific memory CD4 T-cell responses during primary and chronic infection. Blood 100:1381-1387. http://dx.doi.org/10.1182/blood-2001-11-0080.
15. + T cells in vivo. J. Virol. 80:6801-6809. http://dx.doi.org/10.1128/JVI.00070-06.
16. Pear WS, Nolan GP, Scott ML, Baltimore D. 1993. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. U. S. A. 90:8392-8396. http://dx.doi.org/10.1073/pnas.90.18.8392.
17. Keele BF, Giorgi EE, Salazar-Gonzalez JF, Decker JM, Pham KT, Salazar MG, Sun C, Grayson T, Wang S, Li H, Wei X, Jiang C, Kirchherr JL, Gao F, Anderson JA, Ping L-H, Swanstrom R, Tomaras GD, Blattner WA, Goepfert PA, Kilby JM, Saag MS, Delwart EL, Busch MP, Cohen MS, Montefiori DC, Haynes BF, Gaschen B, Athreya GS, Lee HY, Wood N, Seoighe C, Perelson AS, Bhattacharya T, Korber BT, Hahn BH, Shaw GM. 2008. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc. Natl. Acad. Sci. U. S. A. 105:7552-7557. http://dx.doi.org/10.1073/pnas.0802203105.
18. Wilen CB, Parrish NF, Pfaff JM, Decker JM, Henning EA, Haim H, Petersen JE, Wojcechowskyj JA, Sodroski J, Haynes BF, Montefiori DC, Tilton JC, Shaw GM, Hahn BH, Doms RW. 2011. Phenotypic and immunologic comparison of clade B transmitted/founder and chronic HIV-1 envelope glycoproteins. J. Virol. 85:8514-8527. http://dx.doi.org/10.1128/JVI.00736-11.
19. Kutner RH, Zhang X-Y, Reiser J. 2009. Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors. Nat. Protoc. 4:495-505. http://dx.doi.org/10.1038/nprot.2009.22.
20. Goujon C, Jarrosson-Wuillème L, Bernaud J, Rigal D, Darlix J-L, Cimarelli A. 2006. With a little help from a friend: increasing HIV transduction of monocyte-derived dendritic cells with virion-like particles of SIVMAC. Gene Ther. 13:991-994. http://dx.doi.org/10.1038/sj.gt.3302753.
21. + T cell subsets. J. Virol. Methods 195:164-169. http://dx.doi.org/10.1016/j.jviromet.2013.08.029.
22. Groot F, van Capel TMM, Schuitemaker J, Berkhout B, de Jong EC. 2006. Differential susceptibility of naïve, central memory and effector memory T cells to dendritic cell-mediated HIV-1 transmission. Retrovirology 3:52. http://dx.doi.org/10.1186/1742-4690-3-52.
23. + T cells and monocytes from cord and adult blood. AIDS Res. Hum. Retroviruses 14:607-617. http://dx.doi.org/10.1089/aid.1998.14.607.
24. Bleul CC, Wu L, Hoxie JA, Springer TA, Mackay CR. 1997. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc. Natl. Acad. Sci. U. S. A. 94:1925-1930. http://dx.doi.org/10.1073/pnas.94.5.1925.
25. + T cells. J. Virol. 85:644-648. http://dx.doi.org/10.1128/JVI.01851-10.
26. Boursalian TE, Golob J, Soper DM, Cooper CJ, Fink PJ. 2004. Continued maturation of thymic emigrants in the periphery. Nat. Immunol. 5:418-425. http://dx.doi.org/10.1038/ni1049.
27. Kimmig S, Przybylski GK, Schmidt CA, Laurisch K, Möwes B, Radbruch A, Thiel A. 2002. Two subsets of naive T helper cells with distinct T cell receptor excision circle content in human adult peripheral blood. J. Exp. Med. 195:789-794. http://dx.doi.org/10.1084/jem.20011756.
28. + T cell precursor for naive, memory, and regulatory T cells. J. Exp. Med. 207:2883-2894. http://dx.doi.org/10.1084/jem.20100598.
29. Song K, Rabin RL, Hill BJ, De Rosa SC, Perfetto SP, Zhang HH, Foley JF, Reiner JS, Liu J, Mattapallil JJ, Douek DC, Roederer M, Farber JM. 2005. Characterization of subsets of CD4+ memory T cells reveals early branched pathways of T cell differentiation in humans. Proc. Natl. Acad. Sci. U. S. A. 102:7916-7921. http://dx.doi.org/10.1073/pnas.0409720102.
30. Lugli E, Gattinoni L, Roberto A, Mavilio D, Price DA, Restifo NP, Roederer M. 2013. Identification, isolation and in vitro expansion of human and nonhuman primate T stem cell memory cells. Nat. Protoc. 8:33-42. http://dx.doi.org/10.1038/nprot.2012.143.
31. Laguette N, Sobhian B, Casartelli N, Ringeard M, Chable-Bessia C, Ségéral E, Yatim A, Emiliani S, Schwartz O, Benkirane M. 2011. SAMHD1 is the dendritic-and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 474:654-657. http://dx.doi.org/10.1038/nature10117.
32. Hrecka K, Hao C, Gierszewska M, Swanson SK, Kesik-Brodacka M, Srivastava S, Florens L, Washburn MP, Skowronski J. 2011. Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature 474:658-661. http://dx.doi.org/10.1038/nature10195.
33. + T cells. Nat. Med. 18:1682-1687. http://dx.doi.org/10.1038/nm.2964.
34. Goldstone DC, Ennis-Adeniran V, Hedden JJ, Groom HCT, Rice GI, Christodoulou E, Walker PA, Kelly G, Haire LF, Yap MW, de Carvalho LPS, Stoye JP, Crow YJ, Taylor IA, Webb M. 2011. HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase. Nature 480:379-382. http://dx.doi.org/10.1038/nature10623.
35. Lahouassa H, Daddacha W, Hofmann H, Ayinde D, Logue EC, Dragin L, Bloch N, Maudet C, Bertrand M, Gramberg T, Pancino G, Priet S, Canard B, Laguette N, Benkirane M, Transy C, Landau NR, Kim B, Margottin-Goguet F. 2012. SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates. Nat. Immunol. 13:223-228. http://dx.doi.org/10.1038/ni.2236.
36. Buzon MJ, Sun H, Li C, Shaw A, Seiss K, Ouyang Z, Martin-Gayo E, Leng J, Henrich TJ, Li JZ, Pereyra F, Zurakowski R, Walker BD, Rosenberg ES, Yu XG, Lichterfeld M. 2014. HIV-1 persistence in CD4+ T cells with stem cell-like properties. Nat. Med. 20:139-142. http://dx.doi.org/10.1038/nm.3445.
37. Chomont N, El-Far M, Ancuta P, Trautmann L, Procopio FA, Yassine-Diab B, Boucher G, Boulassel M-R, Ghattas G, Brenchley JM, Schacker TW, Hill BJ, Douek DC, Routy J-P, Haddad EK, Sekaly R-P. 2009. HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat. Med. 15:893-900. http://dx.doi.org/10.1038/nm.1972.
38. Korin YD, Zack JA. 1999. Nonproductive human immunodeficiency virus type 1 infection in nucleoside-treated G0 lymphocytes. J. Virol. 73: 6526-6532.
39. Zack JA, Arrigo SJ, Weitsman SR, Go AS, Haislip A, Chen IS. 1990. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61:213-222. http://dx.doi.org/10.1016/0092-8674(90)90802-L.
40. Zhou Y, Zhang H, Siliciano JD, Siliciano RF. 2005. Kinetics of human immunodeficiency virus type 1 decay following entry into resting CD4+ T cells. J. Virol. 79:2199-2210. http://dx.doi.org/10.1128/JVI.79.4.2199-2210.2005.
41. + T cells. J. Virol. 80:6441-6457. http://dx.doi.org/10.1128/JVI.00591-06.
42. + T cells. J. Virol. 85:5220-5223. http://dx.doi.org/10.1128/JVI.00284-11.
43. Dahabieh MS, Ooms M, Simon V, Sadowski I. 2013. A doubly fluorescent HIV-1 reporter shows that the majority of integrated HIV-1 is latent shortly after infection. J. Virol. 87:4716-4727. http://dx.doi.org/10.1128/JVI.03478-12.
44. + T cells in the absence of activating stimuli. J. Virol. 79:14179-14188. http://dx.doi.org/10.1128/JVI.79.22.14179-14188.2005.
45. + T cells but enters naïve cells less efficiently than memory cells. J. Virol. 83:4528-4537. http://dx.doi.org/10.1128/JVI.01910-08.
46. + cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment. Clin. Infect. Dis. 48:787-794. http://dx.doi.org/10.1086/597093.
47. Robbins GK, Spritzler JG, Chan ES, Asmuth DM, Gandhi RT, Rodriguez BA, Skowron G, Skolnik PR, Shafer RW, Pollard RB, AIDS Clinical Trials Group 384 Team. 2009. Incomplete reconstitution of T cell subsets on combination antiretroviral therapy in the AIDS Clinical Trials Group protocol 384. Clin. Infect. Dis. 48:350-361. http://dx.doi.org/10.1086/595888.
48. + count and risk of non-AIDS diseases following initial treatment for HIV infection. AIDS 22:841-848. http://dx.doi.org/10.1097/QAD.0b013e3282f7cb76.